Osteogenic Gene Expression Correlates with Development of Heterotopic Ossification in War Wounds
Overview
Authors
Affiliations
Background: Heterotopic ossification (HO) is a frequent complication of modern wartime extremity injuries. The biological mechanisms responsible for the development of HO in traumatic wounds remain elusive.
Question/purposes: The aims of our study were to (1) characterize the expression profile of osteogenesis-related gene transcripts in traumatic war wounds in which HO developed; and (2) determine whether expression at the mRNA level correlated with functional protein expression and HO formation.
Methods: Biopsy specimens from 54 high-energy penetrating extremity wounds obtained at the initial and final surgical débridements were evaluated. The levels of selected osteogenic-related gene transcripts from RNA extracts were assessed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. As a result of its key role in osteogenesis, the concentration of BMP-2 in the effluent of 29 wounds also was determined.
Results: The transcripts of 13 genes (ALPL [p = 0.006], BMP-2 [p < 0.001], BMP-3 [p = 0.06], COL2A1 [p < 0.001], COLL10A1 [p < 0.001], COL11A1 [p = 0.006], COMP [p = 0.02], CSF2 [p = 0.003], CSF3 [p = 0.012], MMP8 [p < 0.001], MMP9 [p = 0.014], SMAD1 [p = 0.024], and VEGFA [p = 0.017]) were upregulated greater than twofold in wounds in which HO developed compared with wounds in which it did not develop. Gene transcript expression of BMP-2 also correlated directly with functional protein expression in the wounds that formed HO (p = 0.029).
Conclusions: Important differences exist in the osteogenic gene expression profile of wounds in which HO developed compared with wounds in which it did not develop. The upregulation of multiple osteogenesis-related gene transcripts indicates the presence of a proosteogenic environment necessary for ectopic bone formation in traumatic wounds.
Clinical Relevance: Understanding the osteogenic environment associated with war wounds may allow for the development of novel therapeutic strategies for HO.
He S, Hu R, Yao X, Cui J, Liu H, Zhu M Regen Biomater. 2024; 11:rbae116.
PMID: 39398284 PMC: 11471265. DOI: 10.1093/rb/rbae116.
Mizukami Y, Kawao N, Ohira T, Hashimoto D, Okada K, Matsuo O Calcif Tissue Int. 2024; 114(5):535-549.
PMID: 38467838 DOI: 10.1007/s00223-024-01193-5.
Fan J, Gao J, Chen J, Hou J, Liu M, Dang Y J Cell Mol Med. 2023; 27(22):3491-3502.
PMID: 37605888 PMC: 10660630. DOI: 10.1111/jcmm.17919.
Dragon A, Rowe C, Rhodes A, Pak O, Davis T, Ronzier E Methods Protoc. 2023; 6(2).
PMID: 36961042 PMC: 10037587. DOI: 10.3390/mps6020022.
Spreadborough P, Strong A, Mares J, Levi B, Davis T J Orthop Surg Res. 2022; 17(1):422.
PMID: 36123728 PMC: 9484189. DOI: 10.1186/s13018-022-03321-z.